First Nebraska Trust Co Makes New $692,000 Investment in CVS Health Corporation $CVS

First Nebraska Trust Co acquired a new stake in CVS Health Corporation (NYSE:CVS) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 6,687 shares of the pharmacy operator’s stock, valued at approximately $692,000.

Other large investors have also recently modified their holdings of the company. Handelsbanken Fonder AB boosted its stake in CVS Health by 83.6% during the second quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock valued at $112,729,000 after buying an additional 496,124 shares during the period. State Street Corp increased its stake in CVS Health by 2.1% in the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after acquiring an additional 1,245,457 shares during the last quarter. Legal & General Group Plc increased its stake in CVS Health by 0.3% in the 4th quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock worth $738,777,000 after acquiring an additional 31,249 shares during the last quarter. Deutsche Bank AG raised its holdings in shares of CVS Health by 28.4% in the 4th quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock valued at $370,333,000 after acquiring an additional 1,031,998 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. bought a new stake in shares of CVS Health during the 2nd quarter valued at about $49,622,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on CVS shares. Royal Bank Of Canada boosted their price objective on CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Morgan Stanley lifted their target price on shares of CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a research report on Thursday, June 4th. UBS Group boosted their price target on shares of CVS Health from $122.00 to $126.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Mizuho increased their price target on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $113.00 price objective on shares of CVS Health in a report on Monday, June 1st. Twenty-two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Stock Performance

Shares of NYSE CVS opened at $93.01 on Friday. The stock’s 50-day moving average is $102.02 and its 200 day moving average is $88.86. The stock has a market cap of $118.96 billion, a price-to-earnings ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same quarter in the prior year, the firm earned $1.81 earnings per share. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, sell-side analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. CVS Health’s dividend payout ratio is 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.